XOS Prebiotic Supplier India: PreticX®, a xylooligosaccharide (XOS) prebiotic, offers nutraceutical brands an opportunity to develop low-dose prebiotic formulations. With clinical research supporting a 1 g daily dose for its bifidogenic effect, PreticX® can be evaluated across capsules, tablets, gummies, stick packs, beverages and everyday foods.
Gut health products often face a practical formulation challenge: serving size. Many prebiotic fibres are included at several grams per serving, which can make capsules and compact dosage formats difficult to develop.
PreticX® offers a different formulation opportunity. Its low-dose profile gives manufacturers more flexibility when designing supplements and functional foods for everyday use.
For brands looking for an XOS prebiotic supplier in India, ingredient quality, clinical evidence, stability, regulatory documentation and formulation support all matter.
Avlaan Pharma supplies PreticX® for brands and formulators exploring prebiotic ingredients. This guide explains what XOS is, how PreticX® can fit into different product formats, what the research indicates and what to evaluate before selecting a supplier.
Key Takeaways
- PreticX® is a plant-derived xylooligosaccharide (XOS) prebiotic.
- The supplied ingredient information identifies 1 g per day as a clinically supported dose for its bifidogenic effect.
- Its low-dose profile creates formulation opportunities across capsules, tablets, gummies, stick packs and functional foods.
- The supplied technical information reports stability across pH 2.3–8.0 and temperatures of 80–120°C.
- PreticX® has more than 12 published human studies, according to the supplied product information.
- XOS is listed among permitted prebiotic compounds in India’s Schedule IV framework, but finished-product compliance must still be confirmed.
- Brands should use accurate digestive-health and beneficial-bacteria communication rather than disease-treatment claims.
Why the Dose Matters When Choosing an XOS Prebiotic Supplier in India
Dose influences more than the ingredient quantity. It affects product format, serving size, manufacturing requirements and the consumer experience.
When a prebiotic ingredient requires a larger serving, manufacturers may need to consider powders or sachets. A prebiotic with a lower effective serving requirement can offer more flexibility.
PreticX® is described in the supplied technical material as having a clinically supported 1 g daily dose for its bifidogenic effect.
This can create opportunities for:
- Capsules that fit into existing supplement routines.
- Tablets combined with selected vitamins or probiotics.
- Gummies designed around convenient daily consumption.
- Small stick packs that can be mixed into water or juice.
- Functional beverages and everyday food applications.
A lower serving size may also make product development more convenient for consumers who are new to prebiotic fibre. However, tolerance depends on the ingredient, finished formulation and individual consumer.
What Is the Effective Dose of XOS Prebiotic?
The supplied PreticX® product information identifies 1 g per day as a clinically supported dose for its bifidogenic effect, based on research associated with UCLA.
This is ingredient-specific information. Different XOS materials can have different compositions and characteristics, so the results associated with PreticX® should not automatically be applied to every XOS ingredient.
Formulators should request the exact ingredient specification, supporting research and recommended use information before finalising the serving size.
What Is XOS? Understanding Xylooligosaccharides
Xylooligosaccharides, commonly called XOS, are short chains of xylose sugar units derived from xylan, a fibre found in plant cell walls.
XOS resists digestion in the upper gastrointestinal tract and can be fermented in the colon. It is used as a prebiotic ingredient because it can selectively support beneficial bacteria, including Bifidobacteria.
How Is PreticX® Different?
PreticX® is derived from plant xylan. Its specific production process determines its chain composition and ingredient characteristics.
This distinction matters when evaluating research. Clinical findings associated with one particular XOS ingredient should not automatically be used to substantiate claims for another material with a different composition.
For product developers, this means reviewing:
- Ingredient identity and source.
- XOS content and chain profile.
- Technical specifications.
- Batch Certificate of Analysis (CoA).
- Human clinical research on the actual ingredient.
- Vegan and other relevant certification documents.
A supplier should be able to explain the ingredient clearly and provide documentation that supports the formulation team’s assessment.
What 1 Gram of PreticX® Makes Possible: Formulation Options
One of the most interesting aspects of a low-dose prebiotic is the range of formats that manufacturers can evaluate.
| Product format | How a 1 g serving may fit | Formulation considerations |
|---|---|---|
| Capsules | Potentially two standard capsules | Can be evaluated alongside probiotic ingredients |
| Tablets | Potentially one tablet, depending on total formulation weight | Consider compression and space for co-actives |
| Stick packs | Compact serving | Assess dispersion in water or juice |
| Gummies | Can be evaluated within typical gummy formats | Review taste, texture and manufacturing conditions |
| Functional beverages | Can be dosed per bottle | Evaluate pH, processing and finished-product stability |
| Bakery and foods | Small inclusion per serving | Check heat exposure and final product stability |
The exact serving format depends on the complete formulation. Ingredient density, additional actives, excipients, manufacturing equipment and product specifications all affect the final design.
1. Capsules
Capsules can be a convenient option for brands developing daily gut-health supplements.
A low-dose XOS ingredient may leave formulation space for selected probiotics or other complementary ingredients. Check the total fill weight and capsule size before finalising the product.
2. Tablets
Tablets can combine a prebiotic ingredient with selected vitamins, minerals or probiotics.
Manufacturers should assess compression behaviour, hardness, disintegration and compatibility with other formulation components.
3. Stick Packs
Stick packs provide a compact way to deliver a measured serving.
PreticX® can be evaluated for use in powder blends intended for mixing with water or juice. Check dispersion, taste and moisture protection during product development.
4. Gummies
Gummies are another possible format for low-dose prebiotic formulations.
The mild, slightly sweet flavour described in the supplied product information may be useful during sensory development. However, manufacturers should conduct actual taste, texture, processing and stability trials.
5. Functional Beverages
A prebiotic ingredient that can be used at a low inclusion level may provide flexibility when developing ready-to-drink products.
The supplied PreticX® technical information reports stability across pH 2.3–8.0. This makes it worth evaluating in different beverage concepts, including acidic fruit-based drinks.
6. Bakery and Everyday Foods
PreticX® can also be explored in selected food applications, including biscuits, breads, cereals, granola and snack products.
The supplied product information reports heat stability across 80–120°C. Actual performance must be assessed under the processing conditions used in the finished food.
The Clinical Evidence Behind PreticX®
According to the supplied product information, PreticX® has more than 12 published human studies.
Its research background includes UCLA-associated studies investigating the effects of XOS supplementation on gut microbiota.
The 2014 Randomised, Placebo-Controlled Study
The supplied research summary identifies a 2014 study by Finegold and colleagues involving 32 healthy adults.
Participants received:
- 1.4 g of PreticX® daily.
- 2.8 g of PreticX® daily.
- A placebo comparison.
The intervention lasted eight weeks.
According to the supplied summary, Bifidobacterium counts increased in both PreticX® groups compared with placebo.
The 2015 UCLA Pilot Study
The supplied material also references a 2015 UCLA pilot study by Yang and colleagues. It reports changes in gut microbiota at doses as low as 1 g per day.
Together, these studies provide research context for the use of PreticX® as a prebiotic ingredient.
What Does This Mean for Formulators?
The ingredient’s research background can help manufacturers evaluate its suitability for products designed around:
- Supporting beneficial bacteria such as Bifidobacteria.
- Digestive-health formulation concepts.
- Prebiotic and probiotic combinations.
- Daily gut-health supplements.
- Functional foods with prebiotic ingredients.
However, the research findings should be described accurately. The study populations, ingredient doses, duration and measured outcomes matter when developing commercial claims.
Stability Across Indian Formulation and Supply Conditions
Ingredient stability is an important consideration for brands manufacturing products in India.
The supplied PreticX® product information reports:
| Technical parameter | Supplied information |
|---|---|
| pH stability | 2.3–8.0 |
| Temperature stability | 80–120°C |
| Flavour | Mild, neutral and slightly sweet |
| Ingredient source | Plant-derived xylan |
These characteristics provide potential flexibility across different product formats.
Beverage Applications
The reported pH range makes PreticX® worth evaluating in acidic fruit drinks and other functional beverages.
Test the ingredient in the actual beverage base, including the intended processing and packaging conditions.
Bakery and Heat-Processed Foods
The supplied technical information reports heat stability from 80–120°C.
This may make PreticX® relevant to bakery and selected food applications. However, the final ingredient performance should be verified under the actual processing temperature, duration and product conditions.
Powders and Premixes
PreticX® can be considered for health-drink powders, instant beverage mixes, breakfast products and snack applications.
Supplements
Capsules, tablets and gummies offer potential opportunities for low-dose prebiotic products.
Important: Technical stability information does not establish the shelf life of every finished product. Run appropriate stability studies on the final formulation and packaging before assigning a commercial expiry date.
Indian transport and storage conditions can expose products to heat and humidity. Finished-product moisture control and packaging selection should therefore be part of the development process.
Regulatory Status of XOS in India
The supplied article identifies xylooligosaccharides as appearing in Schedule IV, the list of permitted prebiotic compounds under India’s relevant Nutra Regulations framework.
It also identifies a maximum adult daily prebiotic quantity of 40 g and notes specific requirements for prebiotic food labelling.
Before using this information in a commercial product brief, manufacturers should verify the latest applicable FSSAI regulations, amendments, ingredient conditions and product-category requirements.
Regulatory review should include:
- Confirmation that the ingredient is permitted for the intended product category.
- Verification of the applicable use level and daily intake requirements.
- Correct product-category declaration and front-of-pack information.
- Ingredient source and supporting documentation.
- Vegan, non-GMO and other claims where relevant.
- Review of all advertising and product-label claims.
The supplied material also states that PreticX® has FDA GRAS status, EFSA Novel Food approval, Health Canada approval, Non-GMO Project Verification and organic certification.
Brands should request current certificates and supporting documentation from the supplier before using these statuses in product marketing. International approvals do not automatically establish compliance with Indian requirements.
Pairing XOS With Probiotics and Other Ingredients
A low-dose prebiotic can leave more formulation space for complementary ingredients.
The following combinations are potential starting points for product development.
1. XOS With Probiotics
A combination of a prebiotic and a probiotic is commonly described as a synbiotic formulation.
PreticX® can be evaluated alongside selected probiotic strains. Formulators should consider strain compatibility, moisture levels, water activity, storage conditions and the stability requirements of the probiotic.
2. XOS With Fibre Blends
A small PreticX® inclusion can be explored in a broader fibre formulation.
The final combination should have a clear purpose, with ingredient quantities and tolerance assessed in the complete formula.
3. XOS With Vitamins and Minerals
An everyday multivitamin or wellness supplement can be evaluated as a potential format for including a low-dose prebiotic.
Check ingredient compatibility, tablet or capsule capacity and the finished-product regulatory position.
4. Women’s and Family Wellness Products
Gut health may be an area of interest for brands developing daily nutrition and family-wellness ranges.
However, age-specific product suitability, serving quantities and labelling requirements must be independently confirmed. Do not assume that adult formulation requirements apply to children.
Questions to Ask an XOS Prebiotic Supplier in India
Before selecting a supplier, nutraceutical manufacturers should evaluate more than ingredient availability.
Here are seven practical questions to ask.
- Is there human research on this exact XOS ingredient? Request original study citations, doses, study populations and measured outcomes.
- What is the XOS content and chain profile? Ask for the ingredient specification and batch CoA.
- What is the documented effective dose? Confirm the ingredient-specific research and recommended use information.
- What stability data is available? Request pH and temperature data relevant to your intended product format.
- What is the regulatory position in India? Confirm the applicable Schedule IV listing and product-category requirements.
- What documentation is available? Request vegan, non-GMO and organic documentation where applicable.
- Can the supplier support product development? Discuss samples, technical information, formulation considerations and supply requirements.
A reliable supplier should communicate the ingredient’s identity, supporting evidence and limitations clearly.
Responsible Claim Language for XOS Products
Prebiotic products should be marketed with accurate digestive-health communication.
Avoid making claims that suggest disease treatment or guaranteed results.
| Avoid unsupported claims | More appropriate wording to assess, where permitted |
|---|---|
| Cures constipation | Helps support bowel regularity |
| Treats IBS | Helps support a healthy digestive system |
| Fixes your gut | Helps support beneficial bacteria such as Bifidobacteria |
| Clinically proven probiotic | Prebiotic ingredient that can support beneficial bacteria |
| Prevents digestive disorders | Formulated with a prebiotic ingredient for digestive-health support |
These are not automatic approvals for finished-product claims. Every statement should be checked against the applicable FSSAI Advertising and Claims Regulations, product category and available evidence.
A prebiotic is not the same as a probiotic. PreticX® is an XOS prebiotic ingredient; it should not be described as containing live probiotic organisms unless the finished product separately includes them.
Frequently Asked Questions
1. What should I look for in an XOS prebiotic supplier in India?
Look for an ingredient with human research on the specific material, a documented ingredient composition, technical stability information and clear regulatory documentation. Ask for batch CoAs, specifications, vegan and non-GMO documentation where applicable, and support for formulation development.
2. How is XOS different from inulin or FOS?
XOS is made up of xylose units derived from plant xylan, while inulin and fructooligosaccharides (FOS) are fructose-based carbohydrates.
Their composition and fermentation characteristics differ. PreticX® has ingredient-specific research supporting its bifidogenic effect at a low daily dose. Formulators should compare the actual specifications and evidence for each ingredient before choosing one.
3. Is XOS permitted in India?
The supplied material identifies xylooligosaccharides in Schedule IV, the list of permitted prebiotic compounds under India’s Nutra Regulations framework.
However, manufacturers must verify the latest applicable regulations, permitted product category, use conditions, serving limits and labelling requirements before commercial production.
4. Is PreticX® vegan?
The supplied product information states that PreticX® is derived from plant xylan and is suitable for vegan formulations.
However, a finished product’s vegan claim depends on the complete formula, including capsule shells, carriers, processing aids and other ingredients. Confirm the relevant documentation before making the claim.
5. Can PreticX® be combined with probiotics?
Yes, it can be evaluated in a prebiotic-plus-probiotic formulation, commonly described as a synbiotic product.
The formulation team should review the selected probiotic strains, compatibility, moisture levels, water activity, storage conditions and finished-product stability.
6. What is the daily dose of PreticX®?
The supplied product information identifies 1 g per day as a clinically supported dose for its bifidogenic effect. Confirm the current technical specification and recommended use information with the ingredient supplier before finalising the product.
7. Which product formats can use PreticX®?
Potential formats include capsules, tablets, gummies, stick packs, functional beverages, bakery products, cereals and other selected food applications. The final suitability depends on the complete formulation, processing conditions and stability testing.
Source PreticX® From Avlaan Pharma
A prebiotic ingredient’s value depends on more than its inclusion in a product formula. Brands need a clear understanding of its composition, supporting clinical research, technical performance and regulatory position.
PreticX® offers a low-dose XOS formulation opportunity for manufacturers exploring capsules, tablets, gummies, beverages and everyday foods.
Avlaan Pharma supplies PreticX® for nutraceutical brands and formulators looking for an XOS prebiotic ingredient in India. Contact the team to discuss technical specifications, research documentation, samples and formulation requirements.
Contact Avlaan Pharma
- Email: info@avlaanpharma.com
- Phone: +91 735 855 1962
- Website: Avlaan Pharma
Discuss your XOS prebiotic ingredient requirements with Avlaan Pharma and explore PreticX® for your next gut-health formulation.